Literature DB >> 165353

The role of cyclic GMP in the regulation of cyclic AMP hydrolysis.

W L Terasaki, M M Appleman.   

Abstract

A rat-heart cyclic nucleotide phosphodiesterase has been chromatographically separated from related enzymes and its kinetic properties have been studied. The enzyme can hydrolyze both cyclic AMP and cyclic GMP and has about the same maximum velocity and apparent KM (greater than 10-5 M) for the two nucleotides. Kinetic plots indicate positive cooperative behavior for both substrates. Cyclic GMP at low concentrations is a potent activator of cyclic AMP hydrolysis and this activation, as well as the cooperativity, can be abolished by treatment with solvents or sulfydryl reagents under conditions which do not destroy the catalytic function. A kinetic model for this enzyme is porposed and the physiologic role is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165353     DOI: 10.1016/0026-0495(75)90112-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Implications of cross inhibitory interactions of potential mediators of hormone and neurotransmitter action.

Authors:  E Van Cauter; J G Hardman; J E Dumont
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

2.  Identification and characterization of both the cytosolic and particulate forms of cyclic GMP-stimulated cyclic AMP phosphodiesterase from rat liver.

Authors:  N J Pyne; M E Cooper; M D Houslay
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

3.  Theoretical analysis of the consequences of cyclic nucleotide phosphodiesterase negative co-operativity. Amplification and positive co-operativity of cyclic AMP accumulation.

Authors:  C Erneux; J M Boeynaems; J E Dumont
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

4.  Isoelectric-focusing patterns of cyclic nucleotide phosphodiesterase from rat heart.

Authors:  G Némoz; A F Prigent; J F Pageaux; H Pacheco
Journal:  Biochem J       Date:  1981-10-01       Impact factor: 3.857

5.  Characterization of a rat liver cyclic GMP-activated phosphodiesterase by chromatography on hexyl-agarose. Inhibition of phosphodiesterase activity by hexyl-agarose.

Authors:  D Couchie; C Erneux; J E Dumont
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

Review 6.  Phosphodiesterase inhibition by new cardiotonic agents: mechanism of action and possible clinical relevance in the therapy of congestive heart failure.

Authors:  H von der Leyen
Journal:  Klin Wochenschr       Date:  1989-06-15

7.  Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.

Authors:  Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2015-09-23       Impact factor: 5.000

8.  The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.

Authors:  P Methven; M Lemon; K Bhoola
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

9.  Activities and some properties of adenylate cyclase and phosphodiesterase in muscle, liver and nervous tissues from vertebrates and invertebrates in relation to the control of the concentration of adenosine 3':5'-cyclic monophosphate.

Authors:  J R Arch; E A Newsholme
Journal:  Biochem J       Date:  1976-09-15       Impact factor: 3.857

10.  Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.

Authors:  I Mullaney; R A Clegg
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.